Intellia Therapeutics, Inc. (NTLA) quarterly cash flow statement — complete operating, investing & financing history
Intellia Therapeutics, Inc. (NTLA) cash flow statement — 12-year operating, investing & financing cash flows
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 |
|---|
| Cash from Operations | -85.43M | -83.11M | -117.35M | -69.28M | -76.9M | -99.62M | -148.93M | -85.19M | -84.84M | -58.19M | -120.66M | -93.05M | -101.38M | -90.32M | -109.33M | -89.87M | -78.53M | -85.09M | -79.8M | -54.65M |
| Operating CF Margin % | -1192.66% | -1085.17% | -779.81% | -301.02% | -557.97% | -699.35% | -895.71% | -661.76% | -931.15% | -836.37% | -417.01% | 4854.15% | -845.41% | -664.43% | -867.27% | -662.12% | -591.93% | -606.49% | -709.22% | -425.17% |
| Operating CF Growth % | -11.09% | 16.57% | 21.21% | 18.67% | 9.36% | -71.21% | -23.43% | 8.45% | 16.32% | 35.58% | -10.37% | -3.54% | -29.1% | -6.15% | -37% | -64.44% | -20.77% | -60.61% | -52.36% | -35.86% |
| Net Income | -127.48M | -106.63M | -96.23M | -202.11M | -101.32M | -101.25M | -114.33M | -128.9M | -135.71M | -146.97M | -107.44M | -132.16M | -122.22M | -123.68M | -103.13M | -113.41M | -113.23M | -100.68M | -146.87M | -81.24M |
| Depreciation & Amortization | 1.92M | 2.08M | 2.2M | 377K | 4.94M | 2.47M | 2.5M | 2.57M | 2.61M | 2.6M | 2.51M | 2.47M | 2.29M | 2.17M | 2.05M | 2.03M | 1.95M | 1.84M | 1.75M | 1.88M |
| Stock-Based Compensation | 14.4M | 18.07M | 13.48M | 90.79M | 19.6M | 22.04M | 21.84M | 39.62M | 39.62M | 40.86M | 34.18M | 35.04M | 35.35M | 36.4M | 27.25M | 24.63M | 25.21M | 23.07M | 18.49M | 14.56M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -4.08M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 9.64M | -790K | 369K | 41.16M | -4.52M | -3.01M | -155K | -520K | -1.29M | 15.71M | -20.19M | -1.51M | 968K | -237K | 1.39M | 10.3M | 13.18M | 7.93M | 64.39M | 6.9M |
| Working Capital Changes | 16.09M | 4.15M | -37.16M | 494K | 4.41M | -19.87M | -58.78M | 2.04M | 9.94M | 29.62M | -29.73M | 3.11M | -13.69M | -4.97M | -36.9M | -13.42M | -5.64M | -17.24M | -17.57M | 3.25M |
| Change in Receivables | -178K | 1.81M | 337K | 1.58M | 303K | -849K | -1.99M | 337K | 3.47M | 24.1M | 29K | -29.96M | -1.43M | -151K | -1.14M | 255K | -1.17M | -1.05M | 230K | 460K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.24M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -661K | -7.09M | -1.42M | 6.96M | 3.46M | -2.56M | -1.87M | 1.44M | -5.55M | 5.35M | 5.57M | 3.94M | -7.71M | 5.12M | 1.17M | 750K | -1.62M | -3.65M | -57K | 2.4M |
| Cash from Investing | 61.94M | -141.57M | 66.31M | 27.53M | -741K | 106.91M | 94.33M | 151.56M | -7.71M | -24.19M | 5.9M | 45.94M | 79.5M | -34.54M | -122.25M | -30.15M | 47.64M | 95.34M | 47.47M | -159.12M |
| Capital Expenditures | -888K | -1.81M | -79K | -4.78M | -29K | -239K | -735K | -981K | -1.28M | -1.01M | -2.51M | -1.52M | -4.33M | -4.3M | -3.83M | -3.91M | -4.24M | -3.98M | -1.43M | -2.87M |
| CapEx % of Revenue | 12.4% | 23.62% | 0.53% | 20.75% | 0.21% | 1.68% | 4.42% | 7.62% | 14.04% | 14.55% | 8.66% | -79.29% | 36.12% | 31.64% | 30.4% | 28.82% | 31.94% | 28.37% | 12.7% | 22.31% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -83.83M | 0 | 118.42M | 56.24M | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 267K | 90K | 0 | 123.43M | 0 | 0 | 0 | 0 | 20.97M | 0 | 0 | 0 | 83.83M | 0 | -118.42M | -56.24M | 150K | 0 | -44.83M | 0 |
| Cash from Financing | 73.46M | 196.12M | 33.57M | 1.98M | 114.86M | 14.65M | 0 | 2.32M | 82.19M | 41.25M | 59.99M | 106.48M | 19.1M | 2.52M | 2.22M | 505.76M | 23.98M | 5.89M | 47.32M | 2.28M |
| Debt Issued (Net) | 73.46M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | 194.58M | 33.57M | 1.98M | 114.76M | 13.41M | 0 | -30K | 80.5M | 38.4M | 58.03M | 103.61M | 14.72M | 2.52M | 1.47M | 503.65M | 23.25M | 0 | 38.88M | 2.28M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 1.54M | 0 | 0 | 97K | 1.24M | 0 | 2.35M | 1.7M | 2.85M | 1.96M | 2.87M | 4.38M | 0 | 755K | 2.11M | 722K | 5.89M | 8.44M | 0 |
| Net Change in Cash | 49.97M | -28.57M | -20.77M | -37.92M | 37.22M | 21.94M | -54.6M | 68.69M | -10.35M | -41.13M | -54.77M | 59.37M | -2.78M | -122.34M | -229.35M | 385.74M | -6.91M | 16.15M | 14.99M | -213.23M |
| Free Cash Flow | -86.32M | -84.92M | -117.42M | -69.41M | -76.93M | -99.86M | -149.66M | -86.18M | -86.12M | -59.2M | -123.17M | -94.57M | -105.71M | -94.62M | -113.16M | -93.78M | -82.76M | -89.07M | -126.06M | -57.52M |
| FCF Margin % | -1205.05% | -1108.79% | -780.34% | -301.56% | -558.18% | -701.02% | -900.13% | -669.38% | -945.19% | -850.91% | -425.67% | 4933.44% | -881.53% | -696.07% | -897.67% | -690.94% | -623.87% | -634.86% | -1120.35% | -447.48% |
| FCF Growth % | -12.21% | 14.96% | 21.54% | 19.45% | 10.67% | -68.69% | -21.51% | 8.88% | 18.54% | 37.44% | -8.84% | -0.85% | -27.73% | -6.23% | 10.23% | -63.04% | -18.98% | -59.29% | -130.09% | -39.5% |
| FCF per Share | -0.62 | -0.64 | -0.99 | -0.64 | -0.70 | -0.96 | -1.45 | -0.85 | -0.85 | -0.61 | -1.29 | -1.05 | -1.19 | -1.07 | -1.29 | -1.15 | -1.09 | -1.17 | -1.69 | -0.77 |
| FCF Conversion (FCF/Net Income) | 0.67x | 0.78x | 1.22x | 0.72x | 0.76x | 0.98x | 1.30x | 0.66x | 0.63x | 0.40x | 1.12x | 0.70x | 0.83x | 0.73x | 1.06x | 0.79x | 0.69x | 0.85x | 0.54x | 0.67x |
| Interest Paid | 557K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |